Drug Discovery

The transition from inert chemical compounds to a self-sustaining biological entity represents one of the most profound frontiers in modern science, and researchers at the University of Minnesota have recently bridged this gap by constructing a synthetic structure that mirrors the fundamental

Within the immensely complex and crowded biological environment of the human anatomy, approximately thirty-seven trillion individual cells are constantly engaged in a silent, microscopic dialogue that dictates the fundamental parameters of health and disease. This intricate communication network

The mystery of why specific genetic markers lead to schizophrenia has long remained one of the most significant challenges in modern neuroscience, leaving researchers to puzzle over the vast gaps between static DNA maps and actual patient symptoms. For decades, the scientific community relied

The traditional view of acute myeloid leukemia as a localized disease of the bone marrow is undergoing a radical transformation as researchers uncover the sophisticated ways this cancer colonizes distant organs like the lungs. While clinical experts have long recognized that respiratory failure is

The integration of sophisticated biotechnology into mechanical engineering has reached a significant milestone as researchers at the University of Basel successfully demonstrated a modular nanorobot capable of autonomous task execution. Rather than relying on the static designs that once limited

Ivan Kairatov is a titan in the biopharmaceutical sector, recognized for his pioneer work in integrating generative artificial intelligence into the traditional drug discovery pipeline. With a career spanning decades in research and development, Kairatov has been a vocal advocate for moving beyond